Terbutryn

CAS No. 886-50-0

Terbutryn( —— )

Catalog No. M24906 CAS No. 886-50-0

Terbutryn is a selective herbicide and a triazine compound. It acts as an inhibitor of photosynthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 47 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Terbutryn
  • Note
    Research use only, not for human use.
  • Brief Description
    Terbutryn is a selective herbicide and a triazine compound. It acts as an inhibitor of photosynthesis.
  • Description
    Terbutryn is a selective herbicide and a triazine compound. It acts as an inhibitor of photosynthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    photosynthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    886-50-0
  • Formula Weight
    241.36
  • Molecular Formula
    C10H19N5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (414.32 mM)
  • SMILES
    CSC1=NC(NC(C)(C)C)=NC(NCC)=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • A-18-F-NH2 |Morphine...

    Neuropeptide AF (cattle), an amidated octadecapeptide, is RFamide neuropeptide. Neuropeptide AF (cattle) acts as a ligand of Mas-related gene receptor A4 (MrgprA4) (Mas-related G-protein-coupled Receptor (MRGPR)) (EC50 of ~60 nM) and MrgprC11 (EC50 of ~300 nM). Neuropeptide AF (cattle) also activate to the G protein-coupled receptors NPFF1 (Neuropeptide Y Receptor) (EC50 of ~25-325 nM) and NPFF2 (EC50 of ~1-5 nM). Neuropeptide AF (cattle) shows anti-opiate and related pain modulation effects.

  • Methyl 3-indolecarbo...

    Methyl 3-indolecarboxylate is a natural product isolated from Heracleum candicans.

  • Foslinanib

    Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.